United States · FDA National Drug Code directory

Olmesartan medoxomil

A source-listed medicine record.

Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.

Medicine identity

Source reference
72205-166_c81a0bea-32c1-4a0a-ac3c-5afe99cecdf2
Product NDC
72205-166
Form
TABLET, FILM COATED
Composition / generic term
Olmesartan medoxomil
Labeler
Novadoz Pharmaceuticals LLC
Marketing category
ANDA
Marketing start / end (source format)
20230118
Source listing expiry
20261231

Source-listed ingredients

  • OLMESARTAN MEDOXOMIL — 20 mg/1

These values do not establish equivalence or a dose recommendation.

Packages

  • 30 TABLET, FILM COATED in 1 BOTTLE (72205-166-30) · 72205-166-30
  • 1000 TABLET, FILM COATED in 1 BOTTLE (72205-166-66) · 72205-166-66
  • 90 TABLET, FILM COATED in 1 BOTTLE (72205-166-90) · 72205-166-90
  • 10 BLISTER PACK in 1 CARTON (72205-166-99) / 10 TABLET, FILM COATED in 1 BLISTER PACK (72205-166-11) · 72205-166-99

Source and coverage

Open FDA National Drug Code directory

Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.

Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.

Browse United States records →